Prakash S. Masand, MD
- 32Articles
- 70.8KReads
- 1998–2025Active
- 52Collaborators
- 353Citations
About
Prakash S. Masand, MD, affiliated with Duke-NUS in Singapore, has authored 32 articles between 1998 and 2025 focusing on psychiatric and neurological conditions. His publications cover major depressive disorder, schizophrenia and schizoaffective disorders, bipolar disorder, anxiety, seizures, and cognition, with attention to pharmacological treatments such as cariprazine, vilazodone, escitalopram, paroxetine, and aripiprazole. He has also explored clinical topics including cognitive dysfunction in psychiatric illness, medication adherence in schizophrenia, and augmentation strategies for treatment-resistant depression. His work frequently appears in Psychiatrist.com, including The Journal of Clinical Psychiatry and The Primary Care Companion for CNS Disorders.
Publications
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder
August 6, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.